GSK
GlaxoSmithKline expands Canadian manufacturing plant
June 20, 2011Manufacturing and Production GSK, pharma manufacturing news
GlaxoSmithKline has set aside almost £19 million ($31 million) to expand a manufacturing facility in Ontario, Canada, creating 70 additional …
GSK takes control of China vaccines venture
June 15, 2011Manufacturing and Production, Research and Development, Sales and Marketing China, GSK, Shenzhen Neptunus Interlong Bio-Technique Co, vaccines
GlaxoSmithKline is increasing its footprint in China, shelling out £24 million ($39 million) to buy the remaining stake in a …
Arecor and GSK collaborate on vaccine technology
June 15, 2011Manufacturing and Production, Research and Development Arecor, GSK, vaccines
GSK is to team up with UK company Arecor to develop advanced formulations of GSK’s vaccines. Cambridge-based Arecor has developed …
GSK’s epilepsy treatment Potiga wins US approval
June 13, 2011Sales and Marketing GSK, Potiga, Trobalt, Valeant, epilepsy
The FDA has approved GlaxoSmithKline and Valeant’s epilepsy treatment Potiga, but the drug will require further review before it can …
GSK and Merck cut vaccine prices
June 6, 2011Sales and Marketing Bill and Melinda Gates Foundation, GSK, Merck & Co, developing world, vaccines
GlaxoSmithKline and Merck & Co have pledged to offer their rotavirus vaccines at discounted prices to developing countries. GSK is …
GSK sales suffer double-digit drop
April 28, 2011Sales and Marketing GSK, GlaxoSmithKline
GlaxoSmithKline saw a hefty drop in revenue in the first three months of this year as it struggled to contend …
GlaxoSmithKline OTC sale puts two plants on the block
April 19, 2011Manufacturing and Production GSK, US, pharma manufacturing
GlaxoSmithKline’s decision to sell off a swathe of over-the-counter medicines means that a manufacturing facility in Memphis, Tennessee, has been …
GlaxoSmithKline to drop Alli and other OTC products
April 15, 2011Research and Development, Sales and Marketing Alli, GSK, OTC, Tyverb
GlaxoSmithKline is to sell off its weight loss drug Alli and other less profitable non-prescription drugs. GSK announced its decision …
GSK pilots wireless sensors to improve plant efficiency
April 11, 2011Manufacturing and Production API, GSK, Ireland
GlaxoSmithKline has started pilot testing of a wireless system of flow and pressure transmitters to try to improve the efficiency …
GSK and Valeant’s epilepsy treatment approved
April 8, 2011Sales and Marketing GSK, Trobalt, Valeant, epilepsy
The European Commission has granted marketing authorisation for Trobalt, the new epilepsy drug from GSK and Valeant. Trobalt (retigabine) has …
GSK details $28.5m of research payments to US institutions
April 1, 2011Research and Development GSK, payments
GlaxoSmithKline has made public the payments it gave last year to US institutions engaged in clinical research on its behalf. …
GSK withdraws applications for Avodart
March 25, 2011Research and Development Avodart, Cancer, GSK, bph, prostate cancer
GlaxoSmithKline has withdrawn all regulatory applications for Avodart to prevent prostate cancer after regulators raised doubts about its benefit/risk profile. …
GSK to fund schools science programme
March 23, 2011Research and Development, Sales and Marketing GSK, GlaxoSmithKline, King's College, school science
GlaxoSmithKline has followed its pledge to refund the tuition fees of UK graduates it takes on with a less direct …
GSK Parkinson’s drug impresses at phase III
March 21, 2011Research and Development ADVANCE-PD, GSK, GlaxoSmithKline, IPX066, Impax Pharmaceuticals, Parkinson's disease, Parkinson’s disease
GlaxoSmithKline’s advanced Parkinson’s disease drug IPX066 has impressed in a head to head trial against it nearest rival. The phase …
GSK in manufacturing research collaboration with university
March 18, 2011Manufacturing and Production Advanced Manufacturing, Centre for Innovative Manufacturing in Emergent Macromolecular Therapies, EPSRC fund, GSK, GlaxoSmithKline, Manufacturing Fellowships, academic research, pharma manufacturing
Research into a cutting-edge area of pharmaceutical manufacturing in the UK is to be supported by a new £51 million …
Latest content
ESTEVE CDMO adds $17.5m to Illinois expansion
Brenntag and dsm-firmenich expand biopharma vitamin partnership
